CIA SANEAMENTO BASICO DE-ADR (SBS) Fundamental Analysis & Valuation

NYSE:SBS • US20441A1025

Current stock price

28.77 USD
-0.24 (-0.83%)
At close:
28.77 USD
0 (0%)
After Hours:

This SBS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. SBS Profitability Analysis

1.1 Basic Checks

  • SBS had positive earnings in the past year.
  • In the past year SBS had a positive cash flow from operations.
  • SBS had positive earnings in each of the past 5 years.
  • SBS had a positive operating cash flow in each of the past 5 years.
SBS Yearly Net Income VS EBIT VS OCF VS FCFSBS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B 10B 15B

1.2 Ratios

  • SBS has a Return On Assets of 8.12%. This is amongst the best in the industry. SBS outperforms 92.86% of its industry peers.
  • SBS has a Return On Equity of 19.96%. This is amongst the best in the industry. SBS outperforms 100.00% of its industry peers.
  • With an excellent Return On Invested Capital value of 10.21%, SBS belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for SBS is significantly above the industry average of 4.53%.
Industry RankSector Rank
ROA 8.12%
ROE 19.96%
ROIC 10.21%
ROA(3y)8.56%
ROA(5y)7.1%
ROE(3y)19.23%
ROE(5y)15.67%
ROIC(3y)11.56%
ROIC(5y)9.45%
SBS Yearly ROA, ROE, ROICSBS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • Looking at the Profit Margin, with a value of 22.21%, SBS is in the better half of the industry, outperforming 78.57% of the companies in the same industry.
  • In the last couple of years the Profit Margin of SBS has grown nicely.
  • The Operating Margin of SBS (32.95%) is better than 71.43% of its industry peers.
  • In the last couple of years the Operating Margin of SBS has grown nicely.
  • The Gross Margin of SBS (36.77%) is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of SBS has remained more or less at the same level.
Industry RankSector Rank
OM 32.95%
PM (TTM) 22.21%
GM 36.77%
OM growth 3Y16.29%
OM growth 5Y5.54%
PM growth 3Y16.22%
PM growth 5Y32.36%
GM growth 3Y2.08%
GM growth 5Y0.01%
SBS Yearly Profit, Operating, Gross MarginsSBS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. SBS Health Analysis

2.1 Basic Checks

  • SBS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • SBS has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for SBS has been reduced compared to 5 years ago.
  • SBS has a worse debt/assets ratio than last year.
SBS Yearly Shares OutstandingSBS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
SBS Yearly Total Debt VS Total AssetsSBS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • SBS has an Altman-Z score of 2.11. This is not the best score and indicates that SBS is in the grey zone with still only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.11, SBS belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
  • A Debt/Equity ratio of 0.83 indicates that SBS is somewhat dependend on debt financing.
  • SBS has a better Debt to Equity ratio (0.83) than 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF N/A
Altman-Z 2.11
ROIC/WACC0.85
WACC12%
SBS Yearly LT Debt VS Equity VS FCFSBS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B 20B 30B 40B

2.3 Liquidity

  • SBS has a Current Ratio of 1.12. This is a normal value and indicates that SBS is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Current ratio value of 1.12, SBS is doing good in the industry, outperforming 64.29% of the companies in the same industry.
  • SBS has a Quick Ratio of 1.12. This is a normal value and indicates that SBS is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of SBS (1.12) is better than 78.57% of its industry peers.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 1.12
SBS Yearly Current Assets VS Current LiabilitesSBS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. SBS Growth Analysis

3.1 Past

  • SBS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.22%.
  • The Earnings Per Share has been growing by 55.37% on average over the past years. This is a very strong growth
  • Looking at the last year, SBS shows a small growth in Revenue. The Revenue has grown by 5.39% in the last year.
  • Measured over the past years, SBS shows a quite strong growth in Revenue. The Revenue has been growing by 16.44% on average per year.
EPS 1Y (TTM)-8.22%
EPS 3Y41.27%
EPS 5Y55.37%
EPS Q2Q%110.19%
Revenue 1Y (TTM)5.39%
Revenue growth 3Y19.98%
Revenue growth 5Y16.44%
Sales Q2Q%43.85%

3.2 Future

  • Based on estimates for the next years, SBS will show a small growth in Earnings Per Share. The EPS will grow by 6.63% on average per year.
  • The Revenue is expected to grow by 11.98% on average over the next years. This is quite good.
EPS Next Y-15.94%
EPS Next 2Y6.63%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year12.14%
Revenue Next 2Y14.53%
Revenue Next 3Y14.11%
Revenue Next 5Y11.98%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
SBS Yearly Revenue VS EstimatesSBS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B 40B
SBS Yearly EPS VS EstimatesSBS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. SBS Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 11.94, the valuation of SBS can be described as very reasonable.
  • SBS's Price/Earnings ratio is rather cheap when compared to the industry. SBS is cheaper than 100.00% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 24.88. SBS is valued rather cheaply when compared to this.
  • Based on the Price/Forward Earnings ratio of 14.20, the valuation of SBS can be described as correct.
  • 100.00% of the companies in the same industry are more expensive than SBS, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.19, SBS is valued a bit cheaper.
Industry RankSector Rank
PE 11.94
Fwd PE 14.2
SBS Price Earnings VS Forward Price EarningsSBS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, SBS is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.57
SBS Per share dataSBS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8 10

4.3 Compensation for Growth

  • SBS has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.22
EPS Next 2Y6.63%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. SBS Dividend Analysis

5.1 Amount

  • SBS has a yearly dividend return of 0.75%, which is pretty low.
  • SBS's Dividend Yield is slightly below the industry average, which is at 2.90.
  • With a Dividend Yield of 0.75, SBS pays less dividend than the S&P500 average, which is at 1.90.
Industry RankSector Rank
Dividend Yield 0.75%

5.2 History

  • The dividend of SBS is nicely growing with an annual growth rate of 20.89%!
  • SBS has paid a dividend for at least 10 years, which is a reliable track record.
  • SBS has decreased its dividend recently.
Dividend Growth(5Y)20.89%
Div Incr Years1
Div Non Decr Years1
SBS Yearly Dividends per shareSBS Yearly Dividends per shareYearly Dividends per share 2016 2017 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

  • 27.93% of the earnings are spent on dividend by SBS. This is a low number and sustainable payout ratio.
  • SBS's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP27.93%
EPS Next 2Y6.63%
EPS Next 3YN/A
SBS Yearly Income VS Free CF VS DividendSBS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B
SBS Dividend Payout.SBS Dividend Payout, showing the Payout Ratio.SBS Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

SBS Fundamentals: All Metrics, Ratios and Statistics

CIA SANEAMENTO BASICO DE-ADR

NYSE:SBS (3/27/2026, 8:04:00 PM)

After market: 28.77 0 (0%)

28.77

-0.24 (-0.83%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryWater Utilities
Earnings (Last)03-15
Earnings (Next)05-07
Inst Owners60.39%
Inst Owner Change-1.54%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap20.15B
Revenue(TTM)38.09B
Net Income(TTM)8.46B
Analysts84
Price Target29.44 (2.33%)
Short Float %0.72%
Short Ratio2.49
Dividend
Industry RankSector Rank
Dividend Yield 0.75%
Yearly Dividend0.65
Dividend Growth(5Y)20.89%
DP27.93%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)72.91%
Min EPS beat(2)63.26%
Max EPS beat(2)82.57%
EPS beat(4)4
Avg EPS beat(4)57.85%
Min EPS beat(4)5.76%
Max EPS beat(4)82.57%
EPS beat(8)6
Avg EPS beat(8)77.45%
EPS beat(12)8
Avg EPS beat(12)51.14%
EPS beat(16)10
Avg EPS beat(16)44.24%
Revenue beat(2)2
Avg Revenue beat(2)65.23%
Min Revenue beat(2)40.42%
Max Revenue beat(2)90.03%
Revenue beat(4)4
Avg Revenue beat(4)46.15%
Min Revenue beat(4)23.03%
Max Revenue beat(4)90.03%
Revenue beat(8)8
Avg Revenue beat(8)47.19%
Revenue beat(12)12
Avg Revenue beat(12)36.71%
Revenue beat(16)16
Avg Revenue beat(16)32.37%
PT rev (1m)0%
PT rev (3m)5.36%
EPS NQ rev (1m)2.84%
EPS NQ rev (3m)25.45%
EPS NY rev (1m)-0.51%
EPS NY rev (3m)-7.02%
Revenue NQ rev (1m)-2.41%
Revenue NQ rev (3m)-2.41%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.66%
Valuation
Industry RankSector Rank
PE 11.94
Fwd PE 14.2
P/S 2.77
P/FCF N/A
P/OCF 12.62
P/B 2.49
P/tB N/A
EV/EBITDA 8.57
EPS(TTM)2.41
EY8.38%
EPS(NY)2.03
Fwd EY7.04%
FCF(TTM)-1.47
FCFYN/A
OCF(TTM)2.28
OCFY7.93%
SpS10.39
BVpS11.56
TBVpS-2.21
PEG (NY)N/A
PEG (5Y)0.22
Graham Number25.04
Profitability
Industry RankSector Rank
ROA 8.12%
ROE 19.96%
ROCE 14.32%
ROIC 10.21%
ROICexc 11.88%
ROICexgc 36.09%
OM 32.95%
PM (TTM) 22.21%
GM 36.77%
FCFM N/A
ROA(3y)8.56%
ROA(5y)7.1%
ROE(3y)19.23%
ROE(5y)15.67%
ROIC(3y)11.56%
ROIC(5y)9.45%
ROICexc(3y)12.75%
ROICexc(5y)10.35%
ROICexgc(3y)57.47%
ROICexgc(5y)49.95%
ROCE(3y)16.22%
ROCE(5y)13.25%
ROICexgc growth 3Y-5.57%
ROICexgc growth 5Y-6.54%
ROICexc growth 3Y19.26%
ROICexc growth 5Y8.67%
OM growth 3Y16.29%
OM growth 5Y5.54%
PM growth 3Y16.22%
PM growth 5Y32.36%
GM growth 3Y2.08%
GM growth 5Y0.01%
F-Score4
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF N/A
Debt/EBITDA 2.37
Cap/Depr 622.09%
Cap/Sales 36.07%
Interest Coverage 4.66
Cash Conversion 56.65%
Profit Quality N/A
Current Ratio 1.12
Quick Ratio 1.12
Altman-Z 2.11
F-Score4
WACC12%
ROIC/WACC0.85
Cap/Depr(3y)356.81%
Cap/Depr(5y)276.92%
Cap/Sales(3y)24.82%
Cap/Sales(5y)22.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.22%
EPS 3Y41.27%
EPS 5Y55.37%
EPS Q2Q%110.19%
EPS Next Y-15.94%
EPS Next 2Y6.63%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.39%
Revenue growth 3Y19.98%
Revenue growth 5Y16.44%
Sales Q2Q%43.85%
Revenue Next Year12.14%
Revenue Next 2Y14.53%
Revenue Next 3Y14.11%
Revenue Next 5Y11.98%
EBIT growth 1Y-18.89%
EBIT growth 3Y39.53%
EBIT growth 5Y22.89%
EBIT Next Year39.65%
EBIT Next 3Y21.78%
EBIT Next 5Y20.06%
FCF growth 1Y-759.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y12.92%
OCF growth 3Y28.21%
OCF growth 5Y10.93%

CIA SANEAMENTO BASICO DE-ADR / SBS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CIA SANEAMENTO BASICO DE-ADR?

ChartMill assigns a fundamental rating of 6 / 10 to SBS.


What is the valuation status for SBS stock?

ChartMill assigns a valuation rating of 5 / 10 to CIA SANEAMENTO BASICO DE-ADR (SBS). This can be considered as Fairly Valued.


How profitable is CIA SANEAMENTO BASICO DE-ADR (SBS) stock?

CIA SANEAMENTO BASICO DE-ADR (SBS) has a profitability rating of 8 / 10.


Can you provide the financial health for SBS stock?

The financial health rating of CIA SANEAMENTO BASICO DE-ADR (SBS) is 5 / 10.


Can you provide the expected EPS growth for SBS stock?

The Earnings per Share (EPS) of CIA SANEAMENTO BASICO DE-ADR (SBS) is expected to decline by -15.94% in the next year.